Point State Capital LP Bio Rad Laboratories, Inc. Transaction History

Point State Capital LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$708.84 - $794.68 $3.19 Million - $3.58 Million	-4,500 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$657.71 - $825.77 $3.62 Million - $4.54 Million	-5,500 Reduced 55.0%	4,500 $3.36 Million
Q2 2021 Aug 13, 2021	BUY	$576.64 - $649.04 $5.77 Million - $6.49 Million	10,000 New	10,000 $6.44 Million
Q3 2018 Nov 14, 2018	SELL	$289.28 - $326.15 $18.6 Million - $21 Million	-64,448 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$233.97 - $274.11 $1.35 Million - $1.58 Million	5,754 Added 9.8%	64,448 $16.1 Million

Q4 2017 Feb 14, 2018	SELL	$216.94 - $271.3 $2.15 Million - $2.69 Million	-9,906 Reduced 14.44%	58,694 $14 Million
Q3 2017 Nov 14, 2017	BUY	$212.27 - $242.28 $14.6 Million - $16.6 Million	68,600	68,600 $15.2 Million

489

17.8M

44.9K

79.7K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $6.82B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Point State Capital LP, based on Form 13F filings with the SEC.

Stay updated on Point State Capital LP with notifications on news.